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Abstract  
Objectives: Fatigue is a major burden among patients with rheumatoid arthritis (RA) yet is 
poorly understood. We sought to conduct the first imaging study to investigate the 
neurobiological correlates of fatigue in RA and to improve upon the methodological 
limitations of previous neuroimaging studies which have investigated this symptom in other 
populations.  
Methods: Chronically fatigued RA patients were clinically characterised before undertaking a 
combined functional and structural mode MRI brain scan. The functional sequences were 
acquired during a fatigue evoking task then network to whole brain analyses were 
undertaken. The structural analyses employed voxel based morphometry in order to quantify 
regional grey matter volume.  The scan was repeated 6 months later to test reproducibility.  
Results: Fifty-four participants attended both scans (n=41 female; baseline mean (SD) age and 
54.94 ± 11.41 years).  A number of significant functional and structural neural imaging 
correlates of fatigue were identified. Notably, patients who reported higher levels of fatigue 
demonstrated higher levels of functional connectivity between the Dorsal Attention Network 
and medial prefrontal gyri  – a finding which was reproduced in the repeat scans.  Structurally, 
greater putamen grey matter volumes significantly correlated with greater levels of fatigue). 
Conclusions: Fatigue in RA is associated with functional and structural MRI changes in the 
brain. The newly identified and reproduced neural imaging correlates provide a basis for 
future targeting and stratification of this key patient priority. 
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Key Messages 
1. Fatigue in rheumatoid arthritis is associated with functional and structural brain 
changes 
2. The neural processes of rheumatoid arthritis fatigue may overlap with those 
related to pain and depression  
 
Introduction 
Fatigue is a symptom which is common to many chronic diseases 1 and is especially prevalent 
and burdensome among musculoskeletal disorders such as rheumatoid arthritis (RA) 2-5.  As 
many as 80% of RA patients report significant levels of fatigue and over 70% consider fatigue 
to be equal to pain in terms of burden6.  Yet patients feel this symptom is disregarded and 
physicians are frustrated by insufficient therapeutic options - a situation that is ultimately 
attributable to our limited mechanistic knowledge of this complex symptom. 
 
Epidemiological investigations of RA related fatigue support a multi-factorial origin. In 
particular, strong associations with central factors such as mental health have been 
commonly reported 6 7.  These observations reinforce evidence from other significantly 
fatigued populations where advanced magnetic resonance imaging (MRI) of the central 
nervous system (CNS) has been the only experimental methodology to consistently identify 
fatigue-related abnormalities8. 
 
MRI methods tested to date include voxel-based morphometry (VBM). This has frequently 
evidenced fatigue-associated structural alterations in grey matter volumes 9 10. Such changes 
are likely to evolve over time, although some studies suggest this may occur in as short as a 
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week following a neuro-modulatory intervention 11.  By contrast, functional MRI (fMRI) 
studies essentially provide a surrogate measure of neuronal activity12. As with other complex 
symptoms (e.g. depression), task-based fMRI paradigms of fatigue have implicated numerous 
diffuse neural correlates indicating that such higher order processes are not limited to single 
regions.  Recent functional connectivity analyses of MRI data (fcMRI) – which assay 
interconnected regions of the brain - has evidenced significant abnormalities related to 
fatigue in the connections between established brain networks in the context of multiple 
sclerosis 13 14 and Parkinson’s disease 15.  
 
Despite the accumulating evidence implicating the brain with fatigue, no consistent regions 
or patterns have been reported. There may be multiple methodological reasons to explain 
this situation. First, variations in analytical approach are common and no studies have 
attempted to validate their results by employing the same design and techniques.  Second, 
almost all existing studies are comprised of small sample sizes (n<30) which are notorious for 
generating unreliable results in neuroimaging 16.  
 
Here we report the first MRI brain study to specifically investigate the neural correlates of 
fatigue in a RA population.  We aimed to improve upon the methodological limitations of 
previous non-RA fatigue neuroimaging studies by recruiting a large sample size and 
incorporating a reproduction phase. We also explored the relationship between fatigue 
specific neural imaging correlates and other clinical factors which are implicated with fatigue 
on an epidemiological level in order to understand whether these associations also exist on a 
neurobiological level.  
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Methods 
Design: Observational cohort study  
Sample: RA patients attending a UK regional rheumatology service were consecutively 
approached. Those who fulfilled the 2010 American College of Rheumatology/European 
League Against Rheumatism (ACR/EULAR) classification criteria 17 and who experienced 
fatigue for >3 months at clinically significant levels  (Chalder fatigue binary scale >3 18) were 
considered eligible. Patients with contra-indications to MRI (e.g. pacemaker in situ), 
alternative medical explanations for fatigue or left handedness, were excluded.  
Full written informed consent was obtained according to the Declaration of Helsinki and then 
these final participants were stratified (1:1) according to those with and without active RA, 
where active disease was defined as a swollen joint count>1. 
We aimed to recruit >50 since this provides the power to detect moderate sized correlations 
at relatively conservative thresholds (i.e., r= .46 for α = .001) and are considered to perform 
well in the functional connectivity analytical approach that we have adopted 19. 
Procedure: All consenting participants underwent a phenotyping battery and multi-modal 
MRI brain scan (Achieva 3T X-series MR system, Philips Medical Systems). This procedure was 
repeated at a second session, 6 months later, for the purposes of reproduction. 
Phenotyping battery (primary and secondary and clinical outcomes): The primary clinical 
outcomes of interest were fatigue assessed by the Bristol Rheumatoid Arthritis Fatigue (BRAF) 
numerical rating scale (NRS) for severity, employing both current and 1 week periods of recall.  
Subjects report a score of 0-10 with anchors of “No fatigue” to “Totally exhausted.  Higher 
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scores reflect greater problems for severity.  The BRAF enjoys high acceptability, test-retest 
reliability and content, construct and criterion reliability20. 
Secondary clinical outcomes were selected based on previous epidemiological studies 
evidencing their role as putative determinants of RA related fatigue: systemic inflammation 
21, C reactive protein (CRP);   pain, current levels of pain severity 6, 0-10 NRS;  sleep disturbance 
22, as measured by the Jenkin’s sleep scale 23;  depression 6,  Hospital Anxiety and Depression 
Scale 24 and  fibromyalgia (FM) 25 , 2011 Fibromyalgia survey score 26.  
MRI brain measures: Images were acquired by a 3 Tesla, 8 channel phased array head coil 
using 3D T1 and T2*-weighted gradient-echo echo-planar imaging pulse sequences. Since 
previous studies of non-RA populations have failed to report common findings, we adopted a 
data driven whole brain search for regions connected to plausible fatigue related networks. 
Functional connectivity MRI (fcMRI): 
Acquisition and pre-processing: see appendix for parameters.  The functional sequences were 
obtained using a block design where a cognitive task (the paced auditory serial additional test 
, PASAT) was undertaken during 3x3 minute ‘on’ periods and interspersed by 4x30 seconds 
rest or ‘off’ periods. The PASAT  has been successfully employed in fMRI paradigms to evoke 
fatigue both in its original and modified forms 27-30, although its capacity to specifically induce 
clinically relevant RA fatigue has yet to be validated.   In this study, subjects listened to a series 
of randomly generated numbers, between 1 to 9 and were asked to add consecutive numbers 
(i.e. the first and the second, the second and the third, etc.).  When two consecutive numbers 
totalled 10, they were asked to press a button. Concurrently they were requested to focus on 
a computer screen displaying three boxes containing randomly changing numbers (between 
1-10). They were instructed not to process the visual numbers whose role is primarily distract 
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the subjects from the auditory task with a view to increasing its complexity and subsequent 
fatigue.   
Independent Component Analysis (ICA): Group ICA was performed using the fMRI Toolbox 
(GIFT) toolbox 31, see appendix for parameters.  Only components previously implicated with 
fatigue were analysed: a) default mode network (DMN) has been associated with cancer 
related fatigue 32 b) dorsal attention network (DAN) with fatigue in AS 10 c) salience network 
(SLN) with chronic fatigue syndrome 33 d) sensorimotor network (SMN) with Parkinson’s 
disease and multiple sclerosis related fatigue 14 15.  
Functional connectivity analysis: Seed to whole brain connectivity was performed using 
the CONN (Cognitive and affective neuroscience laboratory, Massachusetts Institute of 
Technology, Cambridge, MA, USA; www.nitrc.org/projects/conn) functional connectivity 
toolbox v15 in SPM8 34. White matter, CSF, and motion parameters were entered into the 
analysis as covariates of no interest. A band pass filter (frequency window: 0.01–0.1 Hz) was 
applied to remove linear drifts and high frequency noise from the data. The seeds used were 
based on the spatial masks of the intrinsic networks generated from the ICA analyses. The 
onsets of the task periods were included in the analysis, to measure connectivity between the 
network and the rest of the brain during each condition of the scanning period. First-level 
analysis included bivariate correlations between voxels within each network and all voxels 
throughout the whole brain, thereby creating separate beta maps for each individual at each 
session.  Because we were interested in the task period, beta maps that measured network 
connectivity during the PASAT task were then passed onto group second-level analyses in 
SPM8. Here associations in intrinsic network connectivity and current (since this recall period 
better reflects the real-time nature of fcMRI) fatigue NRS during the first session were 
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assessed using a General Linear Model, correcting for age and sex. The resulting maps were 
thresholded at a whole brain p < 0.001 uncorrected voxel threshold and p < 0.05 false 
discovery rate (FDR) cluster corrected for multiple comparisons. Significant regions were 
extracted from first-level network-to-whole brain connectivity maps for each subject by 
obtaining the average fisher transformed r values of the identified clusters.  We then 
performed univariate correlation analyses for all remaining secondary outcomes of interest, 
followed by multivariate regression analyses to establish the independence of any observed 
associations. Finally, reproduction of these significant clusters were tested with a region of 
interest analysis by extracting the average fisher transformed r values of the 5mm spheres - 
created around the significant peak cluster coordinates using the Marsbar toolbox 35 - from 
the relevant second session network connectivity maps obtained 6 months later and then 
correlating with concurrent fatigue values.  These post-hoc analyses were conducted in STATA 
12.1 (Stata, College Station, TX, USA), statistical significance was set at a p-value of 0.05 two-
sided.  
Voxel based morphometry (VBM): 
Acquisition: Inspection of each T-1 weighted fast-field echo data set that was used for 
normalization revealed no gross anatomical abnormalities. 
Pre-processing: The images were then preprocessed using SPM8  using the Diffeomorphic 
Anatomical Registration using the Exponential Lie Algebra (DARTEL) toolbox 36, see appendix 
for approach.  
Statistical analysis: Simple descriptive statistics were used to report patient characteristics. 
Smoothed GM images were entered into a multiple regression analysis in SPM8 with NRS 
fatigue as the covariate of interest ,with a 1 week recall period which is more relevant to MRI 
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metrics such as VBM which take time to change.  .  All analyses were controlled for total 
intracranial volume (the sum of GM, WM and CSF), age and sex. An absolute threshold mask 
of 0.1 was applied to exclude edge effects and non-homogenous voxels. Results were derived 
from a whole brain uncorrected voxel threshold of p < 0.001 and deemed significant at p < 
0.05 FDR corrected for multiple comparisons. Significant regions were extracted from the 
normalized, smoothed GM images for each subject resulting in raw GM values that were 
imported into STATA 12.1 for post-hoc correlations with other clinical symptoms. Again, we 
were interested in validating the observed structural changes from session 1 at the repeat 
session 6 months later.  As similarly described above, the ROIs were defined as the 5mm 
spheres created around the significant peak cluster co-ordinates from the session 1 whole 
brain analyses. We extracted participant specific raw GM volumes for all of the voxels within 
each ROI in session 2, and then performed regression analyses to examine the relationship 
with the primary clinical outcomes in STATA 12.1 (total intracranial volume, age, sex 
corrected).  Statistical significance was set at a p-value of 0.05 two-sided. 
 
Results 
Patient characteristics:  Of the 335 patients approached, 54 met eligibility criteria and 
attended both MRI sessions (mean (SD) age 54.94 ± 11.41 years; n=41 female; mean (SD) 
disease duration 11.49 ± 8.64 years).  Levels of fatigue and other clinical characteristics were 
comparable between visits (table 1).  The PASAT significantly (p<0.001) increased fatigue 
during both visits (visit 1: mean increase 2.35 SD 1.75; visit 2: mean increase 1.44 SD 2.23)  
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[Table 1 insert] 
Functional brain network to region connections relate significantly to levels of fatigue  
Network to whole brain analysis of the baseline visit identified a number of significant 
connections which related to current levels of fatigue (figure 1).  All a priori selected networks, 
except for SLN, were associated with at least one region (table 2).  There was a significant 
correlation between SMN connectivity to the L insula and current NRS fatigue (r=0.48, 
p=0.012, FDR corrected).  Similar positive correlations were recorded for DMN-R middle 
frontal gyrus (r=0.59, p=0.017, FDR corrected), DAN-L medial prefrontal cortex (r=0.50, 
p=0.043, FDR corrected) and DAN-R medial prefrontal cortex (r=0.56, p<0.001, FDR corrected) 
functional connections.   
Region of interest analysis of session 2 data reproduced the significant associations between 
DAN to L and R medial frontal connectivity and current fatigue (figure 2 and  table 3).  
[Table 2, 3 insert] 
Regional grey matter volumes are significantly associated with fatigue  
Patients with greater grey matter putamen volumes reported higher average 1 week levels of 
fatigue (right: r=0.31, p=0.03, corrected for total intracranial volume, age, sex and FDR) (figure 
3 and supplementary table 1). However, The R putamen grey matter volume was not 
significant at session 2 (r = 0.20, p=0.17).  L putamen grey matter volume was  significantly 
associated with fatigue (1 week average) 6 months later (r= 0.30, p=0.03, corrected for total 
intracranial volume, age and sex).  
Neural imaging correlates of fatigue are associated with other clinical features 
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Some brain regions demonstrating functional connections with a priori networks relating to 
current fatigue, were also significantly (albeit less strongly) correlated with other clinical 
features previously implicated with fatigue in RA (supplementary table 2). The SMN-L insula 
connection correlated with pain, both current and chronic widespread aspects, – as captured 
by the ACR FM scale. The DMN-R middle frontal and DAN-R medial prefrontal connections 
both related to FM and depression, while the DAN-L medial prefrontal was also associated 
with depression in addition to current levels of pain.  Neither inflammation nor sleep 
disturbance appeared relevant to any of these specific functional connections.  Multivariate 
analysis, adjusting for all outcomes of interest, identified current fatigue as the principal 
independent association for each of these functional connections (supplementary tables 3-
6). 
 
Depression was significantly associated with greater putamen grey matter volume (r=0.35, 
p=0.01 and r=0.40, p=0.003, R and L respectively). No other clinical associations with putamen 
grey matter volume were noted (CRP, pain, sleep disturbance, FM all p>0.05). 
 
Discussion 
This is the first study to examine the role of the CNS in fatigue among RA patients.  Moreover, 
to the best of our knowledge, it is the largest multi-modal MRI brain investigation of co-
morbid fatigue to have been conducted in any disease and the only study to test 
reproducibility.  We have identified a number of functional and structural neural imaging 
correlates of RA related fatigue.  In particular, patients who reported higher levels of fatigue 
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demonstrated higher levels of functional connectivity between the DAN and bilateral medial 
prefrontal gyri – a finding which was reproduced on repeat scanning.  Structurally, greater 
putamen grey matter volumes also seemed to correlate with greater levels of fatigue.  Finally, 
while the identified neural regions most strongly and independently related to fatigue, many 
also associated with other clinical features  such as pain and depression.  This further 
evidences the multifactorial nature of this key symptom at a neurobiological level.  
Large proportions of neuroimaging results (including all known fatigue studies)  fail to be 
reproduced 37. The reproduction of the association between fatigue and DAN-medial 
prefrontal functional hyperconnectivity in the second set of scans is therefore reassuring.  
Anatomically, the DAN constitutes the frontal eye fields (a region at the intersection of the 
middle frontal and pre-central gyri) and the posterior parietal sulcus, both structurally 
connected by the superior longitudinal fasciculus. A key role of this major functional network 
is the top-down guided control of attention in response to predictable stimuli 38 which 
complements the ventral attention network’s bottom-up control of attention in response to 
unexpected stimuli. Interestingly, these networks interface within the medial prefrontal gyrus 
where they are known to dynamically interact with each other 38. A previous functional 
connectivity study of fatigue related to mild traumatic brain injury (mTBI) implicated the 
medial prefrontal gyrus with significant fatigue. Subjects undertook a complex cognitive task 
and the authors speculated that subtle brain structural injuries in mTBI led to a disruption to 
the attentional functional networks involving the medial prefrontal gyrus.  The subsequent 
extra effort required to maintain task performance may then result in up-regulation of 
functional connectivity in relation to the attention networks 39.  Furthermore, a structural MRI 
study of ankylosing spondylitis (AS) related fatigue found individual fatigue scores to be 
negatively correlated with grey matter volumes of the dorsal and ventral attention networks 
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as well as reductions in the white matter integrity of the superior longitudinal fasciculus 10.  
Certainly the close association between attention and fatigue has been commonly reported 
in the psychology literature. Kaplan et al described the neuropsychological phenomenon 
‘directed attention fatigue’ as a consequence of an imbalance in the brain’s attention 
mechanisms 40. 
Not all functional connections were reproduced, although there was a trend towards 
significance for the SMN-Insula and we have previously related DMN-frontal connectivity in 
cancer related fatigue32.   
The prominence of the putamen in relation to fatigue  is also noticeable, although statistical 
significance and laterality was not consistent between time points and so this may be a 
spurious finding.  It is, however, striking to note that an identical positive correlation was 
observed between the putamen grey matter volume and fatigue in the only other 
neuroimaging study of co-morbid fatigue in an inflammatory arthritis (AS) 10 thus implying 
that this may be a generic fatigue pathway.  Certainly, without a general population control 
group we are unable to attribute the identified neural imaging correlates specifically to RA.  
Biologically, the putamen mediates reward responses 42 and so inactivity may translate into 
low motivation levels: a key dimension of fatigue in RA 5.  We speculate that the greater 
putamen grey matter volumes observed among the more fatigued RA patients might 
represent a compensatory mechanism in response to low putamen activity.  
It appears that many fatigue CNS pathways could also be relevant to other clinical features.  
This current study evidences shared neurobiological associations with a number of candidate 
factors.  For example, depression can clinically overlap with fatigue in RA 43.  
Neurobiologically, the medial prefrontal gyrus is a recognised neural hub of depression 44 and 
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so it is intriguing to observe its co-existing association with fatigue in this cohort. The current 
analyses, in light of the existing literature, biologically validates the multifactorial nature of 
RA related fatigue, and begins to  delineate overlapping pathways and so potentially aiding 
the future stratification of patients towards the most appropriate mechanism informed 
treatments. 
Unlike many previous neuroimaging investigations of fatigue, our study has been primarily 
designed to investigate this prevalent symptom.  Moreover, we sought to learn from previous 
methodological weaknesses in fatigue neuroimaging research from other populations by 
recruiting a large sample and incorporating a reproduction phase. However, certain study 
limitations exist.  Firstly, as previously mentioned, without control groups this study is unable 
to inform the specificity of the identified neural imaging correlates.  Indeed, given the 
aforementioned similarities in the literature of other clinical conditions, it could be speculated 
that the neural correlates of fatigue are generic.  Secondly, these analyses are cross-sectional 
and so the identified neural regions are not necessarily causal.  Alternatively, they may reflect 
downstream markers. This, nonetheless, would still represent progress since currently no 
reproducible objective measures of fatigue currently exist. The multitude of subjective fatigue 
measures vary greatly in their reliability 20 and their development have never been informed 
by the physiological construct of interest.  Thirdly, although functional connectivity is mainly 
considered a measure of intrinsic communication networks (i.e. sub-conscious brain activity) 
45, it is possible that the PASAT (a task design to test attentional capacity and known to 
enhance brain activation within the attention brain networks 46) has unmasked the 
importance of the DAN.  While this strengthens the neuropsychological rationale for the 
importance of attention in the context of fatigue, it does mean that future attempts to 
replicate this finding using non-task based ‘resting state’ paradigms may be unsuccessful.  
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Moreover, while we appear to have evidenced the fatiguing nature of the PASAT, we must 
recognise that the experience of the MRI scanner can be fatiguing in itself and so potentially 
contributary to our observations. Finally, this task is likely to evoke other dimensions of 
cognition and it us unknown whether the fatigue is clinically relevant or more akin to the 
normal phenomenon of tiredness.  
In the future, applying machine learning methodologies to even larger sample sizes may help 
stratify fatigued patients according to a specific mechanistic pathway and subsequent triage 
towards a personalised treatment.  For example, a patient with a neurobiological signature 
which overlaps between fatigue and depression may benefit from anti-depressants. In 
parallel, neuromodulation of the identified correlates offers one way to test the causality of 
the selected neural regions and, if found to alleviate fatigue, offers a potential therapy for 
primary fatigue. Whether these correlates are disease specific or generic is unknown. Further 
validation of neuroimaging studies in distinct fatigue populations are required. Finally, the 
highlighted role of the DAN, emphasises the potential importance of attention in RA related 
fatigue.  Behavioural interventions, such as mindfulness, can be effective in enhancing 
attention 47 and so may also have a role in treating fatigue.   
In summary, we report the first study to directly implicate the CNS in the pathophysiology of 
fatigue among RA patients.  Higher levels of fatigue related significantly to a number of 
functional and structural changes in the brain.  These neural imaging correlates were also 
relevant to other clinical features, mirroring the multifactorial nature of fatigue inferred from 
previous epidemiological studies.  This data not only provides preliminary targets for much 
needed primary fatigue therapies, but also forms a basis for the future neurobiological 
stratification of patients. Fatigue is the most heterogeneous of constructs and so ultimately 
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clinicians require the tools to ensure individual patients receive the most mechanistically 
relevant treatments for their individual fatigue. 
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Tables 
Table 1: Mean clinical characteristics 
 Baseline visit 6 month visit 
RA disease activitya  3.62±1.30 3.39±1.36 
CRP (mg/L) 7.78±8.54 7.52±10.81 
Fatigue (current)b 4.59±2.19 4.91±2.01 
Fatigue (1 week average)c 6.19±1.82 5.52±1.99 
Sleep disturbanced 15.67±5.46 14.46±5.60 
Current Paine 3.81±2.38 2.91±1.92 
Depression f 6.89±3.92 6.13±3.80 
aDisease activity score 28; bCurrent fatigue 0-10 numerical rating scale (NRS); cAverage NRS of fatigue during the past 7 days; d Jenkin’s sleep 
scale; eCurrent pain NRS; fHospital Anxiety and Depression Scale 
 
Table 2: Network to whole brain connectivity associations corrected for age and sex with 
current fatigue (session 1) 
Network 
FC region (direction of 
association) 
MNI co-ordinates 
(x, y, z) 
Z score 
Cluster size 
(voxels) 
p 
value, 
FDR 
Sensorimotor (SMN) 
L Insula (+ve) 
 
-44, 14, -8 
 
4.50 
 
166 
 
0.012 
Default mode (DMN) 
R Middle Frontal (+ve) 
 
42, 56, 26 
 
4.27 
 
169 
 
0.017 
Dorsal attention (DAN) 
L Medial Prefrontal (+ve) 
R Medial Prefrontal (+ve) 
 
-10,50,-12 
8, 54, 0 
 
3.70 
4.59 
 
102 
300 
 
0.043 
<0.001 
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Table 3: Region of interest functional connectivity reproduction of current fatigue analysis 
(session 2) 
Network 
FC region 
Pearson correlation co-efficient   
 
p value 
Sensorimotor (SMN) 
L Insula 
 
0.21 0.13 
Default mode network 
(DMN) 
R Middle Frontal 
0.09 0.52 
Dorsal attention network 
(DAN) 
L Medial Prefrontal  
R Medial Prefrontal 
 
 
0.28 
0.32 
 
 
0.040 
0.020 
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Figures 
 
Figure 1: Increased brain connectivity between the SMN and Left Insula (A); DMN and Right 
Middle Frontal Gyrus (B); DAN and bilateral medial prefrontal cortex (C) in is associated with 
current levels of fatigue in patients with rheumatoid arthritis. Scatter plots show positive 
correlations for interindividual differences in brain connectivity (Fisher transformed r-values; 
x-axis) and the current fatigue ratings (y-axis). 
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Figure 2: The association between DAN-bilateral prefrontal hyperconnectivity and current 
fatigue ratings was reproduced on repeat scanning. The significant session 2 cluster (BLUE) is 
superimposed on the significant session 1 cluster (ORANGE). Scatter plots show positive 
correlations for interindividual differences in brain connectivity (Fisher transformed r-values; 
x-axis) and current fatigue ratings (y-axis). 
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Figure 3: Patients with greater grey matter putamen volumes reported higher average 1 week 
levels of fatigue. Scatter plots show positive correlations for inter-individual differences in 
grey matter volumes (raw volumes; x-axis) and 1 week average fatigue (y-axis), bcorrected for 
total intracranial volume, age, and sex. The R but not L putamen grey matter volumes were 
statistically significant.  
 
NB: All brain illustrations are presented at p=0.005 FDR threshold. 
 
 
